Literature DB >> 24865965

Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation.

Seda Ghazaryan1, Chandler Sy1, Tinghui Hu1, Xiuli An2, Narla Mohandas3, Haiqing Fu4, Mirit I Aladjem4, Victor T Chang5, Rene Opavsky6, Lizhao Wu7.   

Abstract

Rb is critical for promoting cell cycle exit in cells undergoing terminal differentiation. Here we show that during erythroid terminal differentiation, Rb plays a previously unappreciated and unorthodox role in promoting DNA replication and cell cycle progression. Specifically, inactivation of Rb in erythroid cells led to stressed DNA replication, increased DNA damage, and impaired cell cycle progression, culminating in defective terminal differentiation and anemia. Importantly, all of these defects associated with Rb loss were exacerbated by the concomitant inactivation of E2f8. Gene expression profiling and chromatin immunoprecipitation (ChIP) revealed that Rb and E2F8 cosuppressed a large array of E2F target genes that are critical for DNA replication and cell cycle progression. Remarkably, inactivation of E2f2 rescued the erythropoietic defects resulting from Rb and E2f8 deficiencies. Interestingly, real-time quantitative PCR (qPCR) on E2F2 ChIPs indicated that inactivation of Rb and E2f8 synergizes to increase E2F2 binding to its target gene promoters. Taken together, we propose that Rb and E2F8 collaborate to promote DNA replication and erythroid terminal differentiation by preventing E2F2-mediated aberrant transcriptional activation through the ability of Rb to bind and sequester E2F2 and the ability of E2F8 to compete with E2F2 for E2f-binding sites on target gene promoters.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865965      PMCID: PMC4135565          DOI: 10.1128/MCB.01651-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice.

Authors:  Alain de Bruin; Lizhao Wu; Harold I Saavedra; Pamela Wilson; Ying Yang; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 2.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia.

Authors:  Tinghui Hu; Seda Ghazaryan; Chandler Sy; Charles Wiedmeyer; Victor Chang; Lizhao Wu
Journal:  Blood       Date:  2012-03-14       Impact factor: 22.113

5.  E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.

Authors:  U Ziebold; T Reza; A Caron; J A Lees
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Sublethal radiation injury uncovers a functional transition during erythroid maturation.

Authors:  Scott A Peslak; Jesse Wenger; Jeffrey C Bemis; Paul D Kingsley; Jenna M Frame; Anne D Koniski; Yuhchyau Chen; Jacqueline P Williams; Kathleen E McGrath; Stephen D Dertinger; James Palis
Journal:  Exp Hematol       Date:  2011-02-01       Impact factor: 3.084

8.  Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis.

Authors:  Jing Liu; Jianhua Zhang; Yelena Ginzburg; Huihui Li; Fumin Xue; Lucia De Franceschi; Joel Anne Chasis; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

9.  E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.

Authors:  Ulrike Ziebold; Eunice Y Lee; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.

Authors:  Jing Li; Cong Ran; Edward Li; Faye Gordon; Grant Comstock; Hasan Siddiqui; Whitney Cleghorn; Hui-Zi Chen; Karl Kornacker; Chang-Gong Liu; Shusil K Pandit; Mehrbod Khanizadeh; Michael Weinstein; Gustavo Leone; Alain de Bruin
Journal:  Dev Cell       Date:  2008-01       Impact factor: 12.270

View more
  7 in total

1.  E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts.

Authors:  Kelsey L Swartz; Scott N Wood; Tushar Murthy; Oscar Ramirez; Gangjian Qin; Manoj M Pillai; Sridhar Rao; Alex C Minella
Journal:  Mol Cell Biol       Date:  2016-12-19       Impact factor: 4.272

2.  Repression by RB1 characterizes genes involved in the penultimate stage of erythroid development.

Authors:  Ji Zhang; Melanie R Loyd; Mindy S Randall; John J Morris; Jayesh G Shah; Paul A Ney
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts.

Authors:  Myriam Cuadrado; Javier Garzón; Sergio Moreno; Irene García-Higuera
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

4.  Specific N-cadherin-dependent pathways drive human breast cancer dormancy in bone marrow.

Authors:  Garima Sinha; Alejandra I Ferrer; Seda Ayer; Markos H El-Far; Sri Harika Pamarthi; Yahaira Naaldijk; Pradeep Barak; Oleta A Sandiford; Bernadette M Bibber; Ghassan Yehia; Steven J Greco; Jie-Gen Jiang; Margarette Bryan; Rakesh Kumar; Nicholas M Ponzio; Jean-Pierre Etchegaray; Pranela Rameshwar
Journal:  Life Sci Alliance       Date:  2021-06-02

Review 5.  E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Yi Lv; Jia Xiao; Jing Liu; Feiyue Xing
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

6.  Regulatory network changes between cell lines and their tissues of origin.

Authors:  Camila M Lopes-Ramos; Joseph N Paulson; Cho-Yi Chen; Marieke L Kuijjer; Maud Fagny; John Platig; Abhijeet R Sonawane; Dawn L DeMeo; John Quackenbush; Kimberly Glass
Journal:  BMC Genomics       Date:  2017-09-12       Impact factor: 3.969

7.  Dynamics of Transcription Regulation in Human Bone Marrow Myeloid Differentiation to Mature Blood Neutrophils.

Authors:  Luigi Grassi; Farzin Pourfarzad; Sebastian Ullrich; Angelika Merkel; Felipe Were; Enrique Carrillo-de-Santa-Pau; Guoqiang Yi; Ida H Hiemstra; Anton T J Tool; Erik Mul; Juliane Perner; Eva Janssen-Megens; Kim Berentsen; Hinri Kerstens; Ehsan Habibi; Marta Gut; Marie Laure Yaspo; Matthias Linser; Ernesto Lowy; Avik Datta; Laura Clarke; Paul Flicek; Martin Vingron; Dirk Roos; Timo K van den Berg; Simon Heath; Daniel Rico; Mattia Frontini; Myrto Kostadima; Ivo Gut; Alfonso Valencia; Willem H Ouwehand; Hendrik G Stunnenberg; Joost H A Martens; Taco W Kuijpers
Journal:  Cell Rep       Date:  2018-09-04       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.